Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

Delayed Data
As of Dec 01
 +0.42 / +4.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Aurinia Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 9.50. The median estimate represents a +43.49% increase from the last price of 9.06.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Aurinia Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -61.11%
Growthannually 10.31%


Growthquarterly -18.70%
Growthannually 16.54%
Key to the earnings and sales forecast charts.